BridgeMD
New treatment option for Papillary Thyroid Carcinoma
Official title Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
ClinicalTrials.gov ID: NCT07302672
What this study is testing
- What it's testing
- The goal of this clinical trial is to test whether human-centered nursing care lowers emotional distress and improves quality of life for people who are awake during thyroid thermal ablation. The procedure uses local anesthesia, so participants remain awake and may feel tense.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 60
You may be able to join if
- Age 16-60 years; scheduled for thyroid thermal ablation
- Papillary thyroid carcinoma (PTC)
- Number of target lesions \<= 3
- Largest lesion diameter \<= 2 cm; clinical stage T1N0M0 by imaging
- Awake and able to cooperate under local anesthesia Owns a smartphone and can use WeChat
You likely can't join if
- Serious medical comorbidities or cognitive impairment that precludes participation
- Prior thyroid surgery or thermal ablation
- Unwilling or unable to join the WeChat group or complete postoperative follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.